-
Fertility Outcomes in Men with Prior History of Anabolic Steroid Use Fertil. Steril. (IF 6.7) Pub Date : 2023-09-26 Braian R. Ledesma, Alexander Weber, Greeshma Venigalla, Akhil Muthigi, Jamie Thomas, Manish Narasimman, Joshua White, Ranjith Ramasamy
OBJECTIVE To study sperm parameters recovery and fertility outcomes in men with azoospermia or severe oligospermia caused by anabolic steroid use who underwent a standardized treatment regimen for spermatogenesis recovery. DESIGN AND SUBJECTS: A retrospective analysis of a cohort of men with a prior history of anabolic steroid use and infertility complaints (between 2018 and 2022) was conducted. EXPOSURE
-
Reproductive endocrinology and infertility training: How long is long enough? Fertil. Steril. (IF 6.7) Pub Date : 2023-09-21 Marja Brolinson, Eric A. Widra
Abstract not available
-
Repair of a Chronic Myometrial Defect with Successful Pregnancy Outcome Fertil. Steril. (IF 6.7) Pub Date : 2023-09-23 P.G. Paul, Nirmala Jayasankar, Margi Shah, Mahati Sudhakar, George Paul
Objective Surgical demonstration of pre-conceptional laparoscopic repair of chronic myometrial Defect with mesh reinforcement, resulting in successful pregnancy outcome. Design Video case report. The Institutional Ethical Committee was consulted, and the requirement for approval was waived because the video describes a modified surgical technique. The patient included in this video gave consent for
-
Predictive role of 17α-hydroxy-progesterone serum levels before and after FSH administration in patients with abnormal sperm parameters Fertil. Steril. (IF 6.7) Pub Date : 2023-09-23 Rossella Cannarella, Rosita A. Condorelli, Carmelo Gusmano, Vincenzo Garofalo, Antonio Aversa, Aldo E. Calogero, Sandro La Vignera
Objective To study the possible role of serum 17α-hydroxy-progesterone (17αOH-P) levels in predicting favorable response to follicle-stimulating hormone (FSH) administration to patients with normal serum FSH levels and idiopathic abnormal sperm parameters. Design Prospective cohort study. Setting University-affiliated fertility center. Subjects 50 patients with oligo-, astheno-, and/or teratozoospermia
-
Understanding the Risks Associated with the Transfer of PGT-A Mosaic Embryos-One Perspective, There are Others-A Commentary on Viotti et al. Fertil. Steril. (IF 6.7) Pub Date : 2023-09-22 Gary Harton
Abstract not available
-
Intramyometrial ectopic pregnancy: a very rare presentation of non-tubal ectopic pregnancy Fertil. Steril. (IF 6.7) Pub Date : 2023-09-21 Adolfo F. Rechkemmer
Abstract not available
-
-
-
Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection Fertil. Steril. (IF 6.7) Pub Date : 2023-09-19 Ana Rita Batista, Juan-Enrique Schwarze, Monica Lispi
Abstract not available
-
Sperm Production is Stable Over Time for Men with Azoospermia Factor C (AZFc) Y-Chromosome Microdeletions Fertil. Steril. (IF 6.7) Pub Date : 2023-09-17 Jessica A. Marinaro, Nahid Punjani, Jonathan Gal, Anna Mielnik, Peter N. Schlegel
Abstract not available
-
Exploring a laser-free trophectoderm biopsy method: A commentary on a new innovative approach. Fertil. Steril. (IF 6.7) Pub Date : 2023-09-16 Eva Schenkman
Abstract not available
-
Series of overviews on miscarriage and recurrent miscarriage Fertil. Steril. (IF 6.7) Pub Date : 2023-09-16 Madelon van Wely
Miscarriage is a relatively common occurrence with many knowns and unknowns and a profound psychological impact on individuals and couples. The editors felt it was time to publish a series of overviews for Views and Reviews on both sporadic miscarriage and recurrent miscarriage. The series starts with prevalence of miscarriage and recurrent miscarriage and subsequently describes the psychological impact
-
The complexity of addressing racial and ethnic disparities Fertil. Steril. (IF 6.7) Pub Date : 2023-09-13 Alexandra Huttler, Kim L. Thornton
Abstract not available
-
Evaluating the Endometrial Receptivity Assay: a nested diagnostic accuracy study within the Synchrony randomized clinical trial Fertil. Steril. (IF 6.7) Pub Date : 2023-09-13 Jennifer Chae-Kim, Nicole Doyle, Samad Jahandideh, Jeanne E. O'Brien, Eric A. Widra, Michael Levy, Alan H. DeCherney, Kathleen Devine, Micah J. Hill
Abstract not available
-
Gamete Donors: To Test, or How Much to Test? These are the Questions. Fertil. Steril. (IF 6.7) Pub Date : 2023-09-13
Abstract not available
-
Surgical Techniques for Mini-laparotomy Myomectomy Fertil. Steril. (IF 6.7) Pub Date : 2023-09-09 Miguel Luna Russo, Thomas Gallant, Cara R. King
Context and background The prevalence of uterine fibroids is estimated to be approximately 80%. Fibroids can be associated with abnormal uterine bleeding, pressure symptoms, and infertility. Given this high prevalence, approximately 30,000 myomectomies are performed in the United States per year. Minimally invasive approaches are preferred if feasible. The minimally invasive techniques include, laparoscopic
-
Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion Fertil. Steril. (IF 6.7) Pub Date : 2023-09-09 Alan Penzias, Paula Amato, Jacob Anderson, Kristin Bendikson, Clarisa Gracia, Tommaso Falcone, Rebecca Flyckt, Karl Hansen, Micah Hill, Sangita Jindal, Suleena Kalra, Tarun Jain, Bruce Pier, Michael Thomas, Richard Reindollar, Jared Robins, Chevis N. Shannon, Anne Steiner, Cigdem Tanrikut, Belinda Yauger
This revised document incorporates a growing number of published studies about mosaic embryo transfer (MET) and provides current evidence-based considerations for the clinical management of embryos with mosaic results on preimplantation genetic testing for aneuploidy (PGT-A). This document replaces the document titled “Clinical management of mosaic results from preimplantation genetic testing for aneuploidy
-
Anxiety and depression symptoms during pregnancy and postpartum among parous women with history of infertility Fertil. Steril. (IF 6.7) Pub Date : 2023-09-09 Melissa Pérez Capotosto, Erin Corcoran, Ann Wolbert Burgess, Sheryl L. Rifas-Shiman, Jorge E. Chavarro, Emily Oken
Abstract not available
-
From oocytes to a live birth: are we improving the biological efficiency? Fertil. Steril. (IF 6.7) Pub Date : 2023-09-09 Riwa Sabbagh, Sara Mulligan, Jaimin Shah, Ann Korkidakis, Alan Penzias, Denis Vaughan, Pasquale Patrizio, Denny Sakkas
Objective (s): The objectives of our study were to investigate the live birth rate (LBR) per oocyte retrieved during IVF, in patients who had used all their embryos and to extrapolate the LBR in patients with remaining frozen embryos by calculating the expected LBR from these embryos. Design A retrospective cohort study Setting A single academically affiliated fertility clinic Patient(s) Autologous
-
Meeting the demand for fertility services: the present and future of reproductive endocrinology and infertility in the United States Fertil. Steril. (IF 6.7) Pub Date : 2023-09-04 Eduardo Hariton, Ruben Alvero, Micah J. Hill, Jennifer E. Mersereau, Shana Perman, David Sable, Fiona Wang, Geoffrey David Adamson, Christos Coutifaris, LaTasha B. Craig, Pardis Hosseinzadeh, Anthony N. Imudia, Erica B. Johnstone, Ruth B. Lathi, Paul C. Lin, Erica E. Marsh, Michele Munch, Gloria Richard-Davis, Lauren W. Roth, Amy K. Schutt, Kate Devine
The field of reproductive endocrinology and infertility (REI) is at a crossroads; there is a mismatch between demand for reproductive endocrinology, infertility and assisted reproductive technology (ART) services, and availability of care. This document’s focus is to provide data justifying the critical need for increased provision of fertility services in the United States now and into the future
-
Fertility preservation in Turner girls: to do or not to do? Fertil. Steril. (IF 6.7) Pub Date : 2023-09-02 Jacques Donnez, Marie-Madeleine Dolmans
Abstract not available
-
Hypothermic Machine Perfusion Preservation: a Proof of Concept for Uterus Transplantation. Fertil. Steril. (IF 6.7) Pub Date : 2023-09-01 Ludivine Dion, Carla Sousa, Karim boudjema, David val-laillet, Sylvie jaillard, Nathalie Rioux-leclercq, Erwan Flecher, Vincent Lavoue
Objective To describe the feasibility of Hypothermic Machine Perfusion (HPM) in Uterus Transplantation (UT) to potentially improve the preservation of the uterus to enhance graft preservation in the DBD context. UT is a new surgical approach to treat absolute uterus infertility, it can be performed after living donation (LD) or after Donation after Brainstem Death (DBD). In DBD context, uterus is typically
-
Should we use CRISPR gene editing in human embryos? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-31 Nada Kubikova, David L. Keefe, Dagan Wells, Kutluk H. Oktay, Eve C. Feinberg
Abstract not available
-
Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion Fertil. Steril. (IF 6.7) Pub Date : 2023-08-31
Physicians involved in third-party assisted reproductive technology arrangements who discover material misconduct or other undisclosed information by a party to the arrangement (such as a gamete or embryo donor, gestational carrier, or intended parent) or by a nonmedical professional participant or entity (such as a recruiting program, gamete or embryo bank, or lawyer) should encourage that party or
-
Hysteroscopic Morcellation Versus Curettage for Removal of Retained Products of Conception: A multicenter randomized controlled trial Fertil. Steril. (IF 6.7) Pub Date : 2023-08-30 Liselot P. WAGENAAR, Tjalina W. HAMERLYNCK, Celine M. RADDER, Louisette W. PETERS, Steven WEYERS, Benedictus C. SCHOOT, Huib A. van VLIET
Objective To study the comparison between hysteroscopic morcellation of retained products of conception with ultrasound guided electric vacuum aspiration in terms of intrauterine adhesion formation, as well as efficacy and complications. Design Randomized controlled, non-blinded trial conducted in three teaching hospitals and one university hospital from April 2015 to June 2022. Subjects One-hundred
-
-
-
Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion Fertil. Steril. (IF 6.7) Pub Date : 2023-08-30
Sexually transmitted infections are of major concern to reproductive specialists. Heading the list are human immunodeficiency virus types 1 and 2 and hepatitis B and C viruses. These pathogens, which may cause incurable chronic infections, can be transmitted through assisted reproductive technologies and from infected mothers to the fetus or newborn. This document replaces the document of the same
-
Euploid Programmed Frozen Embryo Transfer Cycles Are Associated with a Higher Live Birth Rate when Estradiol Levels More Closely Mimic Physiology Fertil. Steril. (IF 6.7) Pub Date : 2023-08-28 Nina Vyas, Nissiya Adjei, Steven D. Spandorfer
Objective To determine whether peak estradiol (E2) levels above the usual physiologic range (300-500 pg/mL) will impact programmed frozen embryo transfer (FET) outcomes in an ideal study population of those using good-quality single euploid blastocysts. Design Retrospective cohort study Subjects Single euploid programmed FET done at a single academic institution from January 2016 to December 2019.
-
Genetic causes of sporadic and recurrent miscarriage Fertil. Steril. (IF 6.7) Pub Date : 2023-08-28 Pedro Melo, Rima Dhillon-Smith, Md Asiful Islam, Adam Devall, Arri Coomarasamy
Approximately 80% of miscarriages happen within the first 12 weeks of gestation. More than half of early losses result from genetic defects, usually presenting as abnormal chromosome numbers or gene rearrangements in the embryo. However, the impact of genetics upon pregnancy loss goes well beyond embryonic aneuploidy. For example, the use of big data has recently led to the discovery of specific gene
-
We know all too well the significant psychological impact of miscarriage and recurrent miscarriage: So where is the support? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-28 Jade E. Bilardi, Meredith Temple-Smith
Miscarriage and recurrent miscarriage affect a significant proportion of every population with research consistently showing it results in profound and often prolonged psychological impacts. Despite the serious psychological impacts, support for miscarriage remains grossly inadequate. There are many ways to ameliorate the impact of these losses, which are not difficult, expensive or time-consuming
-
The Prevalence of Sporadic and Recurrent Pregnancy Loss Fertil. Steril. (IF 6.7) Pub Date : 2023-08-28 Haley G. Genovese, Dana B. McQueen
Abstract not available
-
Interventions to prevent miscarriage Fertil. Steril. (IF 6.7) Pub Date : 2023-08-28 Rima K. Dhillon-Smith, Pedro Melo, Rosinder Kaur, Emily Fox, Adam Devall, Natalie Woodhead, Arri Coomarasamy
The physical and psychological impact of miscarriage can be devastating. There are many lifestyle and therapeutic interventions that may prevent a miscarriage. In this review we have outlined the key areas for health optimization to prevent pregnancy loss, drawing on the available up-to-date evidence. The three key areas identified are lifestyle optimization in females, lifestyle optimization in males
-
THE ROLE OF UTERINE NATURAL KILLER CELLS IN RECURRENT PREGNANCY LOSS AND POSSIBLE TREATMENT OPTIONS Fertil. Steril. (IF 6.7) Pub Date : 2023-08-26 Y.L.B.N. Béquet, E.E.L.O. Lashley, M. Goddijn, M.L.P. van der Hoorn
This narrative review summarizes the current knowledge on the role of uterine Natural Killer cells in recurrent pregnancy loss and possible treatment options. Recurrent Pregnancy Loss (RPL) involves two or more consecutive miscarriages, affecting around 3% of couples attempting conception. Despite extensive investigation, causes often remain elusive. Uterine Natural Killer (uNK) cells, critical in
-
The era of surgical enlightenment begins now: appreciating the role different gynecologic subspecialties bring to the infertile patient. Fertil. Steril. (IF 6.7) Pub Date : 2023-08-25 Victoria W. Fitz, Bala Bhagavath, Steven R. Lindheim, John C. Petrozza
Abstract not available
-
The human edit Fertil. Steril. (IF 6.7) Pub Date : 2023-08-26 Sarah C. Cromack, Eve C. Feinberg
Abstract not available
-
Role of infections in miscarriage Fertil. Steril. (IF 6.7) Pub Date : 2023-08-23 Elena B. Kostova, Jelmer R. Prins, Madelon van Wely
Infections with certain pathogens can lead to perinatal complications. Several infections have also been associated with an increased likelihood of a miscarriage. This manuscript discusses these infections, their modes of transmission, the evidence linking them to an increased risk of miscarriage, and whether prevention or treatment strategies are available.
-
Reply of the Authors: Looking Beyond “Promise and Peril” Fertil. Steril. (IF 6.7) Pub Date : 2023-08-23
Abstract not available
-
-
-
Reply of the author: “A day in the life of a reproductive endocrinologist and infertility subspecialist—integration or dissolution?” Fertil. Steril. (IF 6.7) Pub Date : 2023-08-19 Nanette Santoro
Abstract not available
-
Mandated fertility coverage: the resounding choice when morality, medicine, and money align Fertil. Steril. (IF 6.7) Pub Date : 2023-08-19 Sigal Klipstein, Lee Rubin Collins
Abstract not available
-
Timing intrauterine inseminations: Do we need an ultrasound, or can artificial intelligence do the trick? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-16 Eduardo Hariton, Miriam Andrusier, Arian Khorshid
Abstract not available
-
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Fertil. Steril. (IF 6.7) Pub Date : 2023-08-14 Helena J. Teede, Chau Thien Tay, Joop Laven, Anuja Dokras, Lisa J. Moran, Terhi T. Piltonen, Michael F. Costello, Jacky Boivin, Leanne M. Redman, Jacqueline A. Boyle, Robert.J. Norman, Aya Mousa, Anju E. Joham
STUDY QUESTION What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? SUMMARY ANSWER International evidence-based guidelines address prioritized questions and outcomes and include 254 recommendations and practice points, to promote consistent, evidence-based care and improve
-
Müllerian anomalies: Co-conspirators or independent adversaries? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-13 Meghan Yamasaki, Phillip A. Romanski, Benjamin S. Harris
Abstract not available
-
Blinded rebiopsy and analysis of non-euploid embryos with two distinct preimplantation genetic testing platforms for aneuploidy Fertil. Steril. (IF 6.7) Pub Date : 2023-08-11 Sarah Druckenmiller Cascante, Andria Besser, Hsiao-Ling Lee, Fang Wang, Caroline McCaffrey, James A. Grifo
OBJECTIVE To determine how often a non-euploid result from a single trophectoderm biopsy tested with next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) is concordant with rebiopsies tested with a single nucleotide polymorphism (SNP) array-based PGT-A platform. DESIGN Blinded prospective cohort study. SETTING University-affiliated fertility center. PATIENT(s)
-
Fertility preserving management of ovarian torsion Fertil. Steril. (IF 6.7) Pub Date : 2023-08-11 Lejla Sandrieser, Alexandra Perricos, Heinrich Husslein, Rene Wenzl, Lorenz Kuessel
Abstract not available
-
THE TIMING OF SALINE SONOGRAMS IN RESPECT TO PREGNANCY OUTCOMES OF SINGLE EUPLOID EMBRYO TRANSFERS Fertil. Steril. (IF 6.7) Pub Date : 2023-08-11 Koral Cohen, Frederick Licciardi
Abstract not available
-
Can sperm quality affect reproductive outcomes? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-11 Peter N. Schlegel
Current clinical evaluation of male factors poorly predicts assisted reproductive technology outcome. Sperm DNA fragmentation is useful. More advanced analysis of sperm structure and genetics could better assess male reproductive competence.
-
The patient or the blastocyst; which leads to the perfect outcome prediction? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-11 Carla Giménez-Rodríguez, Marcos Meseguer
Abstract not available
-
NEAR-INFRARED AND HYSTEROSCOPY-GUIDED ROBOTIC EXCISION OF UTERINE ISTHMOCELE WITH LASER FIBER: A NOVEL HIGH-PRECISION TECHNIQUE Fertil. Steril. (IF 6.7) Pub Date : 2023-08-09 Zachary Walker, Antonio Gargiulo
Objective To describe a novel high-precision technique for robotic excision of uterine isthmocele, employing a carbon dioxide laser fiber, under hysteroscopic guidance, and near-infrared guidance. Design Video article. Subject(s) A 36-year-old multipara with three prior cesarean sections presented to our infertility clinic with secondary infertility. The patient had been trying to conceive for 6 months
-
Determining the Right ‘Dose’ of Genetic Testing for Gamete Donors Fertil. Steril. (IF 6.7) Pub Date : 2023-08-08 Michelle Bayefsky, David Keefe, Arthur Caplan
Importance Genetic testing of gamete donors is becoming increasingly comprehensive and now often includes expanded carrier screening. Some argue that testing has gone too far, while others propose that testing is not extensive enough. Thinking critically about how much genetic testing is appropriate for gamete donors is crucial for ensuring that market forces alone do not determine the level of testing
-
Association between oocyte donors’ or recipients’ BMI with clinical outcomes after first single blastocyst transfers. The uterus is the mostly affected. Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Gemma Fabozzi, Danilo Cimadomo, Roberta Maggiulli, Alberto Vaiarelli, Vicente Badajoz, Monica Aura, Stefano Canosa, Francesca Bongioanni, Francesca Benini, Claudia Livi, Carlotta Zacà, Andrea Borini, Erminia Alviggi, Benedetta Iussig, Maria Hebles, Pascual Sànchez, Valentino Cimadomo, Laura Rienzi, Joaquìn Llàcer
Objective To assess if high BMI in either oocyte donors or recipients is associated with poorer outcomes after first single blastocyst transfers. Design Retrospective study including 1394 first blastocyst single embryo transfers (SETs) conducted by 1394 recipients during oocyte donation cycles with the gametes retrieved from 1394 women (Jan2019-July2021). Four BMI clusters were defined for both donors
-
Race, ovarian responsiveness, and live birth following in vitro fertilization Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Iris T. Lee, Dara S. Berger, Nathanael Koelper, Suneeta Senapati, Monica Mainigi
Objective To determine if ovarian responsiveness to gonadotropin stimulation differs by race/ethnicity and whether this predicts live birth rates (LBRs) in non-White patients undergoing in vitro fertilization (IVF) Design Retrospective cohort study Subjects White, Asian, Black, and Hispanic patients undergoing ovarian stimulation for IVF at an academic infertility clinic Exposure Self-reported race
-
TurnerFertility trial: Fertility preservation in young girls with Turner syndrome by freezing ovarian cortex tissue - a prospective intervention study Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Sapthami Nadesapillai, Janielle van der Velden, Sanne van der Coelen, Myra Schleedoorn, Amy Sedney, Marian Spath, Maarten Schurink, Anke Oerlemans, Joanna IntHout, Ina Beerendonk, Didi Braat, Ronald Peek, Kathrin Fleischer
Objective Which girls with Turner syndrome (TS) could benefit from fertility preservation by ovarian tissue cryopreservation (OTC) based on karyotype, puberty status and hormonal data? Design Prospective intervention study. Participants were included between 2018 and 2020. Subjects In total, 106 girls with TS, aged between 2 and 18 years were included. Girls with minor X chromosome deletions, Y chromosomal
-
Frozen embryo transfer outcomes decline with increasing female body mass index with female but not male factor infertility: analysis of 56,564 euploid blastocyst transfers Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Jennifer B. Bakkensen, Danielle Strom, Christina E. Boots
Objective To evaluate the association of body mass index (BMI) with cycle outcomes after euploid frozen blastocyst transfer. Design Retrospective cohort study. Setting Not applicable. Patient(s) A total of 56,564 first single autologous euploid frozen embryo transfers (FET) from the 2016-2019 Society for Assisted Reproductive Technology database were analyzed by BMI and by World Health Organization
-
An “iron-clad” link between obesity and accelerated depletion of the ovarian reserve Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Joshua Johnson, Alex J. Polotsky
Abstract not available
-
Letter to “A day in the life of a reproductive endocrinologist and infertility subspecialist—integration or dissolution?” Fertil. Steril. (IF 6.7) Pub Date : 2023-08-05 Marco Mouanness, Zaher Merhi
Abstract not available
-
What is the risk of having repeated surgery in the future? Fertil. Steril. (IF 6.7) Pub Date : 2023-08-02 Horace ROMAN
Abstract not available
-
Oral follicle stimulating hormone (FSH) receptor agonist affects granulosa cells differently than recombinant human FSH Fertil. Steril. (IF 6.7) Pub Date : 2023-07-31 Joie Z. Guner, Diana Monsivais, Henry Yu, Fabio Stossi, Hannah L. Johnson, William E. Gibbons, Martin M. Matzuk, Stephen Palmer
Objective To determine whether TOP5300, a novel oral follicle stimulating hormone receptor (FSHR) allosteric agonist, elicits a different cellular response than recombinant human FSH (rh-FSH) in human granulosa cells from in vitro fertilization patients. Design Basic science research with a preclinical allosteric FSHR agonist. Subjects Infertility patients at a single academic fertility clinic were